Personal Protective Equipment Market Size, Share & Trends Analysis Report By Product (Head Protection, Eye Protection, Face Protection), By End Use (Construction, Manufacturing, Chemicals), By Region, And Segment Forecasts, 2026 - 2033
Description
Personal Protective Equipment Market Summary
The global personal protective equipment market size was estimated at USD 90.42 billion in 2025 and is projected to reach USD 159.76 billion by 2033, at a CAGR of 7.4% from 2026 to 2033. Rising employee health and safety awareness, combined with high industrial deaths in emerging economies due to a shortage of protective equipment, is likely to fuel market expansion over the forecast period.
Moreover, technological innovations in smart PPE and surging customer demand for protective gear is a mix of attractive design and safety, which are also leading the growth of the market for personal protective equipment.
Within the manufacturing sector, personal protective equipment functions as a necessary safeguard against a wide array of occupational hazards. Ranging from operating heavy machinery to handling chemicals, personal protective equipment, including items such as helmets, safety glasses, gloves, and protective clothing, acts as a crucial line of defense, shielding workers from physical injuries, chemical exposure, and respiratory dangers.
Global Personal Protective Equipment Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global personal protective equipment market report based on product, end use, and region:
The global personal protective equipment market size was estimated at USD 90.42 billion in 2025 and is projected to reach USD 159.76 billion by 2033, at a CAGR of 7.4% from 2026 to 2033. Rising employee health and safety awareness, combined with high industrial deaths in emerging economies due to a shortage of protective equipment, is likely to fuel market expansion over the forecast period.
Moreover, technological innovations in smart PPE and surging customer demand for protective gear is a mix of attractive design and safety, which are also leading the growth of the market for personal protective equipment.
Within the manufacturing sector, personal protective equipment functions as a necessary safeguard against a wide array of occupational hazards. Ranging from operating heavy machinery to handling chemicals, personal protective equipment, including items such as helmets, safety glasses, gloves, and protective clothing, acts as a crucial line of defense, shielding workers from physical injuries, chemical exposure, and respiratory dangers.
Global Personal Protective Equipment Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global personal protective equipment market report based on product, end use, and region:
- Product Outlook (Revenue, USD Billion, 2021 - 2033)
- Head Protection
- Hard Hats
- Bump Caps
- Eye Protection
- Safety Glasses
- Goggles
- Face Protection
- Full Face Shields
- Half Face Shields
- Hearing Protection
- Earmuffs
- Earplugs
- Protective Clothing
- Heat & flame protection
- Chemical defending
- Clean room clothing
- Mechanical protective clothing
- Limited general use
- Others
- Respiratory Protection
- Air-purifying respirator
- Supplied air respirators
- Protective Footwear
- Leather
- Rubber
- PVC
- Polyurethane
- Others
- Fall Protection
- Soft Goods
- Hard Goods
- Others
- Hand Protection
- Disposable by Type
- General purpose
- Chemical handling
- Sterile gloves
- Surgical
- Others
- Disposable by Material
- Natural Rubber
- Nitrile
- Vinyl
- Neoprene
- Polyethylene
- Others
- Durable
- Mechanical gloves
- Chemical handling
- Thermal/flame retardant
- Others
- Others
- End Use Outlook (Revenue, USD Billion, 2021 - 2033)
- Construction
- Manufacturing
- Oil & Gas
- Chemicals
- Food
- Pharmaceuticals
- Healthcare
- Transportation
- Mining
- Others
- Regional Outlook (Revenue, USD Billion, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- Spain
- UK
- Russia
- Scandinavia
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Thailand
- Malaysia
- Indonesia
- Central & South America
- Brazil
- Argentina
- Middle East and Africa
- Saudi Arabia
- UAE
- South Africa
Table of Contents
100 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Device Type
- 1.2.2. Procedure
- 1.2.3. End Use
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecast timeline.
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR’s internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity price analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Device Type Segment
- 2.2.2. Procedure Segment
- 2.2.3. End Use Segment
- 2.2.4. Regional Outlook
- 2.3. Competitive Insights
- Chapter 3. Global Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Increasing prevalence of PAD
- 3.2.1.2. Rising government initiatives
- 3.2.1.3. Technological advancements
- 3.2.2. Market restraint analysis
- 3.2.2.1. High cost associated with the devices and procedures
- 3.2.2.2. Lack of awareness and early diagnosis in rural regions
- 3.3. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
- Chapter 4. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: Device Type Estimates & Trend Analysis
- 4.1. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: Device Type Dashboard
- 4.2. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: Device Type Movement Analysis
- 4.3. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market Size & Forecasts and Trend Analysis, by Device Type, 2021 to 2033 (USD Million)
- 4.4. Endovascular Devices
- 4.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 4.4.2. Balloon Angioplasty Devices Market estimates and forecast 2021 to 2033 (USD Million)
- 4.4.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 4.4.3. Atherectomy Systems Market estimates and forecast 2021 to 2033 (USD Million)
- 4.4.3.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 4.4.4. Stents Market estimates and forecast 2021 to 2033 (USD Million)
- 4.4.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 4.4.4.2. Self-Expanding Stents
- 4.4.4.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 4.4.4.3. Balloon-Expandable Stents
- 4.4.4.3.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 4.4.4.4. Covered Stent Grafts
- 4.4.4.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 4.4.4.5. Bifurcated Aortic Stent Grafts
- 4.4.4.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 4.5. Surgical Devices
- 4.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
- Chapter 5. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: Procedure Estimates & Trend Analysis
- 5.1. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: Procedure Dashboard
- 5.2. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: Procedure Movement Analysis
- 5.3. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market Size & Forecasts and Trend Analysis, by Procedure, 2021 to 2033 (USD Million)
- 5.4. Endovascular Procedures
- 5.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 5.4.2. Balloon Angioplasty Market estimates and forecast 2021 to 2033 (USD Million)
- 5.4.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 5.4.3. Primary Stenting Market estimates and forecast 2021 to 2033 (USD Million)
- 5.4.3.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 5.4.4. Kissing Stents Market estimates and forecast 2021 to 2033 (USD Million)
- 5.4.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 5.4.5. Covered Stent Grafts Market estimates and forecast 2021 to 2033 (USD Million)
- 5.4.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 5.4.6. Endovascular Aortic Repair (EVAR) Market estimates and forecast 2021 to 2033 (USD Million)
- 5.4.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 5.5. Hybrid Procedures
- 5.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 5.6. Open Surgical Procedures
- 5.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
- Chapter 6. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: End Use Estimates & Trend Analysis
- 6.1. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: End Use Dashboard
- 6.2. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: End Use Movement Analysis
- 6.3. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
- 6.4. Hospitals
- 6.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 6.5. Outpatient Facilities
- 6.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 6.6. Others
- 6.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
- Chapter 7. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: Regional Estimates & Trend Analysis by Country, Device Type, Procedure & End Use
- 7.1. Global Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: Regional Dashboard
- 7.2. Market Size & Forecasts Trend Analysis, 2021 to 2033
- 7.3. North America
- 7.3.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Key country dynamics
- 7.3.2.2. Regulatory framework/ reimbursement structure
- 7.3.2.3. Competitive scenario
- 7.3.2.4. U.S. market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.3. Canada
- 7.3.3.1. Key country dynamics
- 7.3.3.2. Regulatory framework/ reimbursement structure
- 7.3.3.3. Competitive scenario
- 7.3.3.4. Canada market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.4. Mexico
- 7.3.4.1. Key country dynamics
- 7.3.4.2. Regulatory framework/ reimbursement structure
- 7.3.4.3. Competitive scenario
- 7.3.4.4. Mexico market estimates and forecast, 2021 - 2033 (USD Million)
- 7.4. Europe
- 7.4.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
- 7.4.2. UK
- 7.4.2.1. Key country dynamics
- 7.4.2.2. Regulatory framework/ reimbursement structure
- 7.4.2.3. Competitive scenario
- 7.4.2.4. UK market estimates and forecast, 2021 - 2033 (USD Million)
- 7.4.3. Germany
- 7.4.3.1. Key country dynamics
- 7.4.3.2. Regulatory framework/ reimbursement structure
- 7.4.3.3. Competitive scenario
- 7.4.3.4. Germany market estimates and forecast, 2021 - 2033 (USD Million)
- 7.4.4. France
- 7.4.4.1. Key country dynamics
- 7.4.4.2. Regulatory framework/ reimbursement structure
- 7.4.4.3. Competitive scenario
- 7.4.4.4. France market estimates and forecast, 2021 - 2033 (USD Million)
- 7.4.5. Italy
- 7.4.5.1. Key country dynamics
- 7.4.5.2. Regulatory framework/ reimbursement structure
- 7.4.5.3. Competitive scenario
- 7.4.5.4. Italy market estimates and forecast, 2021 - 2033 (USD Million)
- 7.4.6. Spain
- 7.4.6.1. Key country dynamics
- 7.4.6.2. Regulatory framework/ reimbursement structure
- 7.4.6.3. Competitive scenario
- 7.4.6.4. Spain market estimates and forecast, 2021 - 2033 (USD Million)
- 7.4.7. Sweden
- 7.4.7.1. Key country dynamics
- 7.4.7.2. Regulatory framework/ reimbursement structure
- 7.4.7.3. Competitive scenario
- 7.4.7.4. Sweden market estimates and forecast, 2021 - 2033 (USD Million)
- 7.4.8. Norway
- 7.4.8.1. Key country dynamics
- 7.4.8.2. Regulatory framework/ reimbursement structure
- 7.4.8.3. Competitive scenario
- 7.4.8.4. Norway market estimates and forecast, 2021 - 2033 (USD Million)
- 7.4.9. Denmark
- 7.4.9.1. Key country dynamics
- 7.4.9.2. Regulatory framework/ reimbursement structure
- 7.4.9.3. Competitive scenario
- 7.4.9.4. Denmark market estimates and forecast, 2021 - 2033 (USD Million)
- 7.5. Asia Pacific
- 7.5.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
- 7.5.2. China
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Regulatory framework/ reimbursement structure
- 7.5.2.3. Competitive scenario
- 7.5.2.4. China market estimates and forecast, 2021 - 2033 (USD Million)
- 7.5.3. Japan
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Regulatory framework/ reimbursement structure
- 7.5.3.3. Competitive scenario
- 7.5.3.4. Japan market estimates and forecast, 2021 - 2033 (USD Million)
- 7.5.4. India
- 7.5.4.1. Key country dynamics
- 7.5.4.2. Regulatory framework/ reimbursement structure
- 7.5.4.3. Competitive scenario
- 7.5.4.4. India market estimates and forecast, 2021 - 2033 (USD Million)
- 7.5.5. Australia
- 7.5.5.1. Key country dynamics
- 7.5.5.2. Regulatory framework/ reimbursement structure
- 7.5.5.3. Competitive scenario
- 7.5.5.4. Australia market estimates and forecast, 2021 - 2033 (USD Million)
- 7.5.6. Thailand
- 7.5.6.1. Key country dynamics
- 7.5.6.2. Regulatory framework/ reimbursement structure
- 7.5.6.3. Competitive scenario
- 7.5.6.4. Thailand market estimates and forecast, 2021 - 2033 (USD Million)
- 7.5.7. South Korea
- 7.5.7.1. Key country dynamics
- 7.5.7.2. Regulatory framework/ reimbursement structure
- 7.5.7.3. Competitive scenario
- 7.5.7.4. South Korea market estimates and forecast, 2021 - 2033 (USD Million)
- 7.6. Latin America
- 7.6.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
- 7.6.2. Brazil
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Regulatory framework/ reimbursement structure
- 7.6.2.3. Competitive scenario
- 7.6.2.4. Brazil market estimates and forecast, 2021 - 2033 (USD Million)
- 7.6.3. Argentina
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Regulatory framework/ reimbursement structure
- 7.6.3.3. Competitive scenario
- 7.6.3.4. Argentina market estimates and forecast, 2021 - 2033 (USD Million)
- 7.7. MEA
- 7.7.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
- 7.7.2. Saudi Arabia
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Regulatory framework/ reimbursement structure
- 7.7.2.3. Competitive scenario
- 7.7.2.4. Saudi Arabia market estimates and forecast, 2021 - 2033 (USD Million)
- 7.7.3. South Africa
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Regulatory framework/ reimbursement structure
- 7.7.3.3. Competitive scenario
- 7.7.3.4. South Africa market estimates and forecast, 2021 - 2033 (USD Million)
- 7.7.4. UAE
- 7.7.4.1. Key country dynamics
- 7.7.4.2. Regulatory framework/ reimbursement structure
- 7.7.4.3. Competitive scenario
- 7.7.4.4. UAE market estimates and forecast, 2021 - 2033 (USD Million)
- 7.7.5. Kuwait
- 7.7.5.1. Key country dynamics
- 7.7.5.2. Regulatory framework/ reimbursement structure
- 7.7.5.3. Competitive scenario
- 7.7.5.4. Kuwait market estimates and forecast, 2021 - 2033 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
- 8.2. Company/Competition Categorization
- 8.3. Vendor Landscape
- 8.3.1. List of key distributors and channel partners
- 8.3.2. Key customers
- 8.3.3. Key company analysis, 2025
- 8.3.4. BD.
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. Bentley InnoMed
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. Scitech Medical
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. Abbott
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. Boston Scientific Corporation
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Product benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. W. L. Gore & Associates, Inc.
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Product benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. Medtronic
- 8.3.10.1. Company overview
- 8.3.10.2. Financial performance
- 8.3.10.3. Product benchmarking
- 8.3.10.4. Strategic initiatives
- 8.3.11. Cook
- 8.3.11.1. Company overview
- 8.3.11.2. Financial performance
- 8.3.11.3. Product benchmarking
- 8.3.11.4. Strategic initiatives
- 8.3.12. Terumo Corporation
- 8.3.12.1. Company overview
- 8.3.12.2. Financial performance
- 8.3.12.3. Product benchmarking
- 8.3.12.4. Strategic initiatives
- 8.3.13. iVascular
- 8.3.13.1. Company overview
- 8.3.13.2. Financial performance
- 8.3.13.3. Product benchmarking
- 8.3.13.4. Strategic initiatives
- 8.3.14. Getinge AB
- 8.3.14.1. Company overview
- 8.3.14.2. Financial performance
- 8.3.14.3. Product benchmarking
- 8.3.14.4. Strategic initiatives
- 8.3.15. Biotronik SE & Co KG
- 8.3.15.1. Company overview
- 8.3.15.2. Financial performance
- 8.3.15.3. Product benchmarking
- 8.3.15.4. Strategic initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
